SANUWAVE HealthSNWV -6.70%38 9-Day RSI is 43.15 as of Jul. 08, 2026. GuruFocus rates SNWV with a GF Score™ of 38/100 and a GF Value™ of $11.98 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 868 Medical Devices & Instruments companies, SANUWAVE Health ranks worse than 53.69% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-08), SANUWAVE Health's 9-Day RSI is 43.15.
The industry rank for SANUWAVE Health's 9-Day RSI or its related term are showing as below:
SNWV's 9-Day RSI is ranked worse than 53.69% of 868
companies
in the Medical Devices & Instruments industry
Industry Median: 49.245
vs SNWV: 43.15
SANUWAVE Health (NAS:SNWV) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
SANUWAVE Health 9-Day RSI Related Terms
SNWV vs RTGN, NNOX, LNSR: 9-Day RSI Comparison
For the Medical Devices subindustry, SANUWAVE Health's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SANUWAVE Health 9-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where SANUWAVE Health's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SANUWAVE Health (SNWV) has a 9-Day RSI of 43.15 as of Jul. 08, 2026. According to the industry distribution chart, SANUWAVE Health ranks #466 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 53.7%.
Is SANUWAVE Health's 9-Day RSI too high?
SANUWAVE Health's current 9-Day RSI is 43.15. The Medical Devices & Instruments industry median 9-Day RSI is 49.25. SANUWAVE Health's value of 43.15 is 12.4% below this industry median. Based on the distribution chart, SANUWAVE Health ranks #466 out of 868 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, SANUWAVE Health has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SANUWAVE Health's 9-Day RSI compare to RTGN and NNOX?
According to the Medical Devices & Instruments industry distribution chart, SANUWAVE Health ranks #466 out of 868 companies for 9-Day RSI. This places SANUWAVE Health in the lower half of its industry. The industry median 9-Day RSI is 49.25. SANUWAVE Health's value of 43.15 is 12.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Devices & Instruments company?
The median 9-Day RSI among Medical Devices & Instruments companies is 49.25, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SANUWAVE Health's current 9-Day RSI of 43.15 is 12.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median 9-Day RSI is 49.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SANUWAVE Health's current 9-Day RSI is 43.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SANUWAVE Health stock overvalued right now?
Based on GuruFocus' analysis, SANUWAVE Health (SNWV) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.98, compared to a current price of $10.10 — trading 15.7% below its estimated fair value. The current 9-Day RSI is 43.15 and 12.4% below the Medical Devices & Instruments industry median of 49.25. SANUWAVE Health's overall GF Score™ is 38/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For SANUWAVE Health (SNWV), the current 9-Day RSI is 43.15 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SANUWAVE Health (SNWV) Overvalued in 2026?
Based on GuruFocus' analysis, SANUWAVE Health stock appears to be undervalued.
The current stock price of $10.10 is trading 15.7% below its estimated GF Value™ of $11.98.
GuruFocus considers SANUWAVE Health to be Modestly Undervalued.
Key valuation signals for SNWV:
9-Day RSI: 43.15
GF Value™: $11.98 vs. price of $10.10 (15.7% below fair value)
Industry Position: 12.4% below the Medical Devices & Instruments median (#466 of 868)
No single metric tells the full story. See the SNWV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
38GF Score
Get the complete analysis for SNWV
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNWV has been successfully added to your 